Related Experiment Videos
Abelson virus-induced lymphomagenesis in mice
The Journal of Experimental Medicine
|September 1, 1978
Summary
Abelson murine leukemia virus (MuLV-A) causes lymphoma in mice. Genetic factors, specifically dominant alleles at Av-1 and Av-2 loci in BALB/c mice, control susceptibility, independent of known leukemia genes.
Area of Science:
- Virology
- Immunogenetics
- Oncology
Background:
- Abelson murine leukemia virus (MuLV-A) is a known inducer of lymphomas in mice.
- Lymphomagenesis is influenced by various factors including age, virus dose, and host genetics.
- Existing knowledge of murine leukemia resistance genes (e.g., Fv-1, Fv-2) does not fully explain MuLV-A susceptibility.
Purpose of the Study:
- To investigate the genetic basis of Abelson virus (MuLV-A) induced lymphoma susceptibility in mice.
- To identify host genes controlling MuLV-A lymphoma induction.
- To understand the role of known and novel genetic loci in MuLV-A pathogenesis.
Main Methods:
- Testing lymphoma induction rates across 16 different mouse strains.
- Utilizing CXB recombinant inbred strains and their hybrids for genetic mapping.
- Performing virologic studies to analyze viral replication and genome interaction.
Main Results:
- Lymphoma induction by MuLV-A is age-dependent, virus dose-dependent, and controlled by host genes.
- BALB/c mice and some derivatives exhibit high sensitivity to MuLV-A.
- Two dominant sensitivity loci, tentatively named Av-1 and Av-2, were identified in BALB/c mice.
- The H-2 major histocompatibility complex may play a minor role in susceptibility.
- Resistance in adult B6 mice is specific to the defective transforming virus genome, not helper virus replication.
Conclusions:
- Host genes, particularly dominant alleles at Av-1 and Av-2, are critical determinants of MuLV-A lymphoma susceptibility.
- These susceptibility genes are distinct from previously characterized murine leukemia resistance genes.
- The findings provide a new framework for understanding the genetic control of retroviral lymphomagenesis.